(Q42443393)

31 October 2017

title

Involvement of nuclear transcription factor-kappa B in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells (English)

1 reference

31 October 2017

5

1 reference

31 October 2017

Kun-Huei Yeh

3

0 references

author name string

Pei-Yen Yeh

series ordinal

1

1 reference

31 October 2017

Shuang-En Chuang

series ordinal

2

1 reference

31 October 2017

Ying Chyi Song

series ordinal

4

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

31 October 2017

published in

Biochemical Pharmacology

1 reference

31 October 2017

volume

66

1 reference

31 October 2017

issue

1

1 reference

31 October 2017

page(s)

25-33

1 reference

Biochemistry of multidrug resistance mediated by the multidrug transporter

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Multidrug resistance--a multiplex phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

MULTIDRUG RESISTANCE IN LEUKAEMIA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Apoptosis: a link between cancer genetics and chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Control of apoptosis by Rel/NF-kappaB transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Aberrant rel/nfkb genes and activity in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

NF- kappa B and chemoresistance: potentiation of cancer drugs via inhibition of NF- kappa B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NF kappa B activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Determining MDR1/P-glycoprotein expression in breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Nuclear extracellular signal-regulated kinase 2 phosphorylates p53 at Thr55 in response to doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Resistance to topoisomerase poisons due to loss of DNA mismatch repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Down-regulation of DNA topoisomerase IIalpha in human colorectal carcinoma cells resistant to a protoberberine alkaloid, berberrubine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

The pro- or anti-apoptotic function of NF-kappaB is determined by the nature of the apoptotic stimulus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Role of NF-κB in p53-mediated programmed cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Increased and correlated nuclear factor-kappa B and Ku autoantigen activities are associated with development of multidrug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

Protein phosphatase X interacts with c-Rel and stimulates c-Rel/nuclear factor kappaB activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

The DNA-dependent protein kinase participates in the activation of NF kappa B following DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

The ATM protein is required for sustained activation of NF-kappaB following DNA damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900250-8

10.1016/S0006-2952(03)00250-8

7 January 2021

Identifiers

DOI

1 reference

31 October 2017

1 reference